DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Referenz

Institute for Quality and Efficiency in Healthcare.
Linaclotide in irritable bowel syndrome: added benefit not proven.
Available at
https://www.iqwig.de/en/press/press-releases/press-releases/linaclotide-in-irritable-bowel-syndrome-added-benefit-not-proven.3693.html . Accessed February 2, 2017

Bibliographische Angaben herunterladen

Suchen in: